Hypothyroidism: the numbers are normal, so why do you still feel unwell?
Levothyroxine fixed the blood test. The fatigue, fog and aches stayed. Here is what the research says about that gap, and what can close it.
Hypothyroidism, or underactive thyroid, is a low level of thyroid hormone, confirmed by a blood test showing low T4 or T3 with a high TSH. Symptoms can include fatigue, feeling cold, a puffy face, constipation, dry skin, hair loss, weight gain, muscle and joint aches, low mood and poor memory. The ATNS Index of Neuroplastic Symptoms is clear that a correctly diagnosed case is a biochemical hormone deficiency, not a neuroplastic symptom, and that symptoms usually respond readily to hormone replacement. It adds that if symptoms do not respond, or are atypical, an assessment for neuroplastic symptoms should be done. Neuroplastic symptoms are real symptoms produced by a sensitized brain and nervous system rather than by the hormone level. Research shows that around one in ten treated patients keep feeling unwell with normal tests, and that psychological factors predict that residual burden better than thyroid markers do. That is where brain-based approaches can help.
This page is about understanding the condition and the role the brain and nervous system can play in it. It is not a diagnosis. Your own clinicians know your case.
What hypothyroidism is
Hypothyroidism means the thyroid gland is not making enough hormone. The diagnosis rests on a blood test: a low free T4 (and sometimes T3) with a raised TSH, the pituitary signal that tells the thyroid to work harder. The most common cause in countries with enough iodine is Hashimoto's thyroiditis, an autoimmune condition.
Symptoms are broad and slow to build: tiredness, feeling the cold, a puffy face, constipation, dry pale skin, brittle nails, hair thinning, weight gain, muscle aches and joint pain, low mood, memory lapses, and heavy periods. Treatment is straightforward: a daily tablet of levothyroxine, with the dose adjusted until TSH returns to the normal range. For most people, symptoms then resolve over weeks to months.
The important point, and the ATNS index makes it first, is that this is a real hormone deficiency with a real fix. Nobody should be told their hypothyroidism is neuroplastic. The question this article addresses is different: what about the people whose tests normalise and who still feel unwell?
The neuroplastic contribution
Neuroplastic symptoms are real physical symptoms produced by learned pathways in the brain and nervous system, a sensitized alarm system, rather than by ongoing damage, disease or, in this case, a hormone shortfall. They are not imaginary, and because the brain can change, they are reversible.
The ATNS Index of Neuroplastic Symptoms states that hypothyroidism is not due to neuroplastic symptoms. It is a biochemical deficiency, and symptoms usually respond readily to treatment. Then it adds the clause that matters for many readers: if symptoms do not respond as expected, or if they are atypical, an assessment for neuroplastic symptoms should be done.
Why would that be? Fatigue, brain fog, aches and low mood are among the most common neuroplastic symptoms in the general population. A period of genuine illness, including untreated hypothyroidism, can teach the nervous system a pattern of tiredness and pain, and once learned the pattern can continue after the cause is gone. Fear that the thyroid is 'still not right', repeated dose changes, and constant monitoring of energy keep the alarm system engaged.
- Learned fatigue. The brain predicts exhaustion and produces it, independent of hormone level. See our article on chronic fatigue.
- Sensitized pain. Muscle and joint aches that persist with normal tests often reflect central sensitization.
- Symptom focus. Attributing every tired afternoon to the thyroid keeps attention locked on the body.
What the research shows
A 2022 review of primary hypothyroidism and quality of life estimates that around 10 to 15 percent of treated patients have persistent symptoms and dissatisfaction despite normal TSH. It notes that these symptoms, chiefly tiredness, low mood and poor concentration, are non-specific and overlap with what is common in the general population, and that proposed explanations include tissue-level hormone issues, ongoing autoimmunity, and psychosocial and physical comorbidities.
A 2025 cross-sectional study asked directly which factors predict thyroid-specific quality of life in treated hypothyroidism. It found that psychological factors, especially somatosensory amplification (the tendency to experience bodily sensations as intense and alarming), along with obesity, predicted quality of life, while thyroid biomarkers, autoimmune activity and markers of tissue hypothyroidism did not. One study cannot settle the question, but it points squarely at the nervous system.
A narrative review on managing symptoms in patients on adequate levothyroxine advises a structured search for non-thyroid causes, including anaemia, other autoimmune disease, sleep disorders and mental health conditions, before adjusting hormone doses further. Two randomised crossover trials cited in a 2023 critical review found that targeting different TSH levels within the normal range did not change symptoms or quality of life.
Signs the brain may be part of the picture
- TSH and free T4 have been normal for months, yet fatigue, aches or fog continue unchanged.
- Several dose adjustments, or a switch to combination T3/T4 therapy, made no lasting difference.
- Symptoms vary with stress, sleep and mood more than with blood results.
- Fatigue that is worst in anticipation of a demanding day, or that lifts during an enjoyable activity.
- Other sensitized-system conditions alongside: IBS, migraine, fibromyalgia, anxiety, insomnia.
Separate the number from the feeling
For one week, keep a two-column note on your phone. Each evening, in the first column, rate your fatigue from 1 to 10. In the second, write one line about the day: sleep, stress, movement, mood, anything notable. Do not look up or think about your last blood result. At the end of the week, read the notes and look for what actually moved the fatigue number. Most people find the pattern follows stress, sleep and meaning far more than any hormone. That observation is the first step in retraining the brain's prediction of exhaustion.
A solution that addresses it
For symptoms that outlast normal thyroid levels, there is an approach that addresses the brain's contribution. Pain and symptom reprocessing teaches the nervous system that the body is no longer in deficit: education about neuroplastic symptoms, somatic tracking of fatigue or aches with curiosity instead of alarm, reducing fear about the thyroid, a graded return to activity using pacing rather than boom and bust, emotional awareness and expression, and acceptance and commitment skills. Trained clinicians deliver it, and digital programs increasingly make it available every day. It sits alongside your levothyroxine, never instead of it.
Cindra is a daily AI companion built around these approaches, with daily check-ins, short practices and plain-language lessons for people whose symptoms have a neuroplastic component. If your tests are normal and you still feel unwell, join the waitlist.
What to do next
Keep taking your thyroid medication exactly as prescribed and never stop or change the dose on your own. Confirm with your clinician that TSH and free T4 are in range and stable, and ask for a check of the common non-thyroid causes of persistent symptoms: iron and B12 levels, coeliac disease, sleep apnoea, depression, and other autoimmune conditions. Seek prompt attention for chest pain, severe breathlessness, confusion, a very slow heart rate or extreme drowsiness.
If that search is clear, ask whether your symptoms fit a neuroplastic pattern. If they might, start learning and practising. Many people find that once they stop waiting for the next blood test to explain their fatigue, the fatigue itself begins to shift.
Questions people ask
Is hypothyroidism a neuroplastic condition?
No. The ATNS index states it is a biochemical hormone deficiency that usually responds readily to treatment. The index recommends assessing for neuroplastic symptoms only when symptoms are atypical or do not respond to treatment as expected.
Why am I still tired on levothyroxine with normal TSH?
Around 10 to 15 percent of treated patients report persistent symptoms. Research finds that psychological factors such as somatosensory amplification predict this residual burden better than thyroid biomarkers do, and that adjusting TSH within the normal range does not usually help. Non-thyroid causes should be checked first.
Should I ask for T3 or a higher dose?
Discuss it with your clinician, but randomised trials have not shown that pushing TSH lower within the normal range improves symptoms. Over-treatment carries heart and bone risks.
References
- Psychological factors and obesity, not thyroid biomarkers, predict thyroid-dependent quality of life in treated hypothyroidism: a cross-sectional study. 2025. PMC12105179
- Primary hypothyroidism and quality of life. 2022. PMC8930682
- Managing symptoms in hypothyroid patients on adequate levothyroxine: a narrative review. PMC7774765
- Critical Approach to Hypothyroid Patients With Persistent Symptoms. 2023. PMC10686697
A daily companion for the hard days and the ordinary ones.
Cindra is an AI companion from Karuna Labs built around acceptance and commitment therapy and the science of neuroplastic symptoms. It checks in with you each day, helps you notice what your symptoms are pulling you away from, and nudges you back toward the things that matter. Cindra is invite-only while we build it with early members.
Join the waitlistThis article is for general education and is not medical advice, and it does not diagnose or treat any condition. Persistent symptoms deserve a proper medical assessment to rule out disease or injury before a neuroplastic explanation is considered. If your symptoms are new, changing, or come with red-flag signs such as fever, unexplained weight loss, numbness or weakness, chest pain, or loss of bladder or bowel control, see a clinician promptly.